Article thumbnail

Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study

By Linda M Rubenstein, Elaine M Smith, Michael Pawlita, Thomas H Haugen, Eva Hamšíková and Lubomir P Turek
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1998). A: HPV 16 E7 antibody levels in cervical cancer patients: before and after treatment.
  2. (1998). Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
  3. (2000). Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma.
  4. (1998). DA: Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection.
  5. (1990). Detection and typing of genital human papillomaviruses.
  6. (1987). EM: Detection of sickle cell anaemia and thalassaemias. Nature
  7. (2003). Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
  8. (2007). Hamsikova E: Human papillomavirus seropositivity and risks of head and neck cancer.
  9. (1995). Herbrink P: Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma.
  10. (1999). Herbrink P: Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papillomavirus type 16 during treatment and follow-up.
  11. (2003). Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study.
  12. (2001). Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
  13. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol
  14. (2005). Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev
  15. (1989). Lemeshow D: Applied Logistic Regression
  16. (1997). Lipman DJ: GAPPED BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res
  17. (2000). LP: p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  18. (2003). Rose BR: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil.
  19. Sidransky D: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. JN a t lC a n c e rI n s t2000,
  20. (2001). SM: Human papillomavirus infection and survival in oral squamous cell cancer: A population-based study. Otolaryngol Head Neck Surg
  21. (1995). Snijders PJ: The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.
  22. (2004). TH, Turek LP: Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
  23. (2008). TH, Turek LP: P16 (ink4a) expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol
  24. (1998). TH: Human papillomavirus and risk of oral cancer. Laryngoscope
  25. (2003). TH: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
  26. (1996). The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer. Gynecol Oncol
  27. (1994). Viscidi RP: Human papillomavirus-related serological markers of invasive Rubenstein et al.
  28. (2000). Vonka V: Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma.